Repligen CorporationRepligen CorporationRepligen Corporation

Repligen Corporation

No trades
See on Supercharts
Market capitalization
‪9.16 B‬USD
‪41.58 M‬USD
‪638.76 M‬USD
‪51.97 M‬
Beta (1Y)
2.56

About Repligen Corporation

CEO
Tony J. Hunt
Headquarters
Waltham
Employees (FY)
‪1.78 K‬
Founded
1981
ISIN
US7599161095
FIGI
BBG000BS48J3
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RGEN is 160.98 USD — it has decreased by 1.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Repligen Corporation stocks are traded under the ticker RGEN.
Repligen Corporation is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Repligen Corporation has a max estimate of 230.00 USD and a min estimate of 180.00 USD.
RGEN earnings for the last quarter are 0.23 USD whereas the estimation was 0.16 USD which accounts for 39.51% surprise. Estimated earnings for the next quarter are 0.33 USD. See more details about Repligen Corporation earnings.
Repligen Corporation revenue for the last quarter amounts to ‪141.19 M‬ USD despite the estimated figure of ‪140.69 M‬ USD. In the next quarter revenue is expected to reach ‪155.38 M‬ USD.
Yes, you can track Repligen Corporation financials in yearly and quarterly reports right on TradingView.
RGEN stock has fallen by 8.76% compared to the previous week, the month change is a 16.13% fall, over the last year Repligen Corporation has showed a 7.54% decrease.
Like other stocks, RGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Repligen Corporation stock right from TradingView charts — choose your broker and connect to your account.
RGEN reached its all-time high on Sep 23, 2021 with the price of 327.32 USD, and its all-time low was 0.50 USD and was reached on Jul 15, 1996.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.78 K‬ employees. See our rating of the largest employees — is Repligen Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Repligen Corporation EBITDA is ‪130.08 M‬ USD, and current EBITDA margin is 20.57%. See more stats in Repligen Corporation financial statements.